Dr. Marty Makary, nominee for FDA commissioner, expressed a commitment to science and rebuilding trust in the FDA during his Senate hearing. He articulated that public trust is crucial for health interventions, referencing the impact of distrust on treatments like pancreatic cancer cures. While facing inquiries about controversial subjects such as the abortion pill mifepristone, Makary refrained from making explicit promises, opting instead for a thorough evaluation of available data and engaging with professional scientists at the FDA. His approach aims at fostering open dialogue and scientific discourse.
If we have the cure for pancreatic cancer, but only 40% of the public is going to come in and take it because the rest don't trust us, then that medication is only 40% effective.
I think we fight bad ideas with more ideas. I don't believe in censorship of scientific opinions. I think we need a civil discourse.
Collection
[
|
...
]